Claude Méric
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Virology 7
- HIV Research and Treatment 5
-
- Cytomegalovirus and herpesvirus research 7
- Herpesvirus Infections and Treatments 6
- Co-authors
- P F Spahr (3 shared papers)Stephen P. Goff (1 shared paper)Stanley A. Plotkin (6 shared papers)Éva Gönczöl (6 shared papers)Édouard W. Khandjian (1 shared paper)Klára Berencsi (5 shared papers)M. Cadoz (4 shared papers)Jean-Luc Darlix (1 shared paper)
- Journals
- Vaccine (6 papers)The Journal of Infectious Diseases (3 papers)Journal of Virology (3 papers)Virus Research (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- FranceUnited StatesHungary
In The Last Decade
Claude Méric
24 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 64
- Virology 552
- Infectious Diseases 513
- Epidemiology 659
- Immunology 420
- Parasitology 111
Countries citing papers authored by Claude Méric
This map shows the geographic impact of Claude Méric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Méric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Méric more than expected).
Fields of papers citing papers by Claude Méric
This network shows the impact of papers produced by Claude Méric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Méric. The network helps show where Claude Méric may publish in the future.
Co-authors
The 25 scholars most cited alongside Claude Méric, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 259 | |
| 2 | 1989 | 232 | |
| 3 | 1986 | 178 | |
| 4 | 1988 | 120 | |
| 5 | 2001 | 115 | |
| 6 | 1995 | 105 | |
| 7 | 1999 | 94 | |
| 8 | 1984 | 71 | |
| 9 | 2001 | 64 | |
| 10 | 1986 | 63 | |
| 11 | The safety and use of canarypox vectored vaccines. | 1995 | 56 |
| 12 | 2002 | 55 | |
| 13 | 1999 | 47 | |
| 14 | 2010 | 46 | |
| 15 | 2010 | 45 | |
| 16 | Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. | 1995 | 30 |
| 17 | 2014 | 28 | |
| 18 | 2001 | 27 | |
| 19 | 2013 | 26 | |
| 20 | 1994 | 22 |
About Claude Méric
Claude Méric is a scholar working on Virology, Epidemiology, Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (7 papers), Herpesvirus Infections and Treatments (6 papers), Mosquito-borne diseases and control (5 papers), HIV Research and Treatment (5 papers), Virus-based gene therapy research (5 papers), Viral Infections and Vectors (4 papers), Viral Infections and Outbreaks Research (4 papers) and Toxoplasma gondii Research Studies (3 papers). The work is most often cited by research in Virology (552 citations), Infectious Diseases (513 citations), Epidemiology (659 citations), Immunology (420 citations) and Parasitology (111 citations). Claude Méric has collaborated with scholars based in France, United States and Hungary. Frequent co-authors include P F Spahr, Stephen P. Goff, Stanley A. Plotkin, Éva Gönczöl, Édouard W. Khandjian, Klára Berencsi, M. Cadoz, Jean-Luc Darlix, John M. Zahradnik and Emmanuel Feroldi. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, Journal of Virology, Virus Research and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.